Enzymatic amplification staining for flow cytometric analysis of cell surface molecules

Cytometry

Volumn 40, Issue 1, 2000, Pages 81-85

  Kaplan, David ^a   Smith, Dawn ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Annexin V; Apoptosis; Cell surface molecules; Enzymatic amplification; Fas ligand; Flow cytometry; Phosphatidylserine; Tyramide

Indexed keywords

CD3 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CD6 ANTIGEN; CD7 ANTIGEN; CELL SURFACE MARKER; FAS LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHOSPHATIDYLSERINE;

ANTIGEN EXPRESSION; ARTICLE; CELL SURFACE; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME CHEMISTRY; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; OPTICAL RESOLUTION; PRIORITY JOURNAL; STAINING;

ANNEXIN A5; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD34; ANTIGENS, CD4; ANTIGENS, CD45; ANTIGENS, CD5; ANTIGENS, CD7; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIGENS, SURFACE; APOPTOSIS; CELL LINE, TRANSFORMED; ENZYME TESTS; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; JURKAT CELLS; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; PHOSPHATIDYLSERINES; SENSITIVITY AND SPECIFICITY;

EID: 0034193172     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(20000501)40:1<81::AID-CYTO11>3.0.CO;2-K     Document Type: Article

References (15)

1. Sieg S, Yildirim Z, Smith D, Kayagaki N, Yagita H, Huang Y, Kaplan D. Herpes simplex virus type 2 inhibition of Fas ligand expression J Virol 1996;70:8747-8751.
2. Sieg S, Smith D, Yildirim Z, Kaplan D. Fas ligand deficiency in HIV disease. Proc Natl Acad Sci USA 1997;94:5860-5865.
3. Smith D, Sieg S, Kaplan D. Aberrant detection of cell surface Fas ligand with anti-peptide antibodies. J Immunol 1998;160:4159-4160.
4. Bobrow MN, Harris TD, Shaughnessy KJ, Litt GL. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J Immunol Methods 1989;125:279-285.
5. Bobrow MN, Shaughnessy DJ, Litt GL. Catalyzed reporter deposition, a novel method of signal amplification II. Application to membrane immunoassays. J Immunol Methods 1991;137:103-112.
6. van Gijlswijk RP, Zijlmans HJ, Wiegant J, Bobrow MN, Erickson TJ, Adler KE, Tanke HJ, Raap AK. Fluorochrome-labeled tyramides: use in immunocytochemistry and fluorescence in situ hybridization. J Histochem Cytochem 1997;45:375-382.
7. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drummond AH, Nagata S. Fas ligand in human serum. Nature Med 1996;2:317-322.
8. Casella CR, Rapaport EL, Finkel TH. Vpu increases susceptibility of human immunodeficiency virus type 1-infected cells to Fas killing. J Virol 1999;73:92-100.
9. Vanags DM, Porn-Ares MI, Coppola S, Burgess DH, Orrenius S, Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J Biol Chem 1996;271:31075-31085.
10. Martin SJ, Reutelingsperger CP. McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DM. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995;182:1545-1556.
11. Earnshaw JC, Osbourn JK, Signal amplification in flow cytometiry using biotin tyramine. Cytometry 1999;35:176-179.
12. Zola H, Neoh SH, Mantizioris BX, Webster J, Loughnan MS. Detection by immunofluorescence of surface molecules present in low copy numbers. J Immunol Methods 1990;135:247-255.
13. Borvak J, Chou C, Bell K, Van Dyke G, Zola H, Ramilo O, Vitetta ES. Expression of CD25 defines peripheral blood mononuclear cells with productive versus latent HIV infection. J Immunol 1995;155:3196-3204.
14. Trunch A, Machy P. Detection of very low receptor numbers on cells by flow cytometry using a sensitive staining method. Cytometry 1987;8:562-567.
15. Scheffold A, Miltenyi S, Radbruch A. Magnetofluorescent liposomes for increased sensitivity of immunofluorescence. Immunotechnology 1995;1:127-137.